These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28419517)

  • 21. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
    Genuardi E; Klous P; Mantoan B; Drandi D; Ferrante M; Cavallo F; Alessandria B; Dogliotti I; Grimaldi D; Ragaini S; Clerico M; Lo Schirico M; Saraci E; Yilmaz M; Zaccaria GM; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; van Min M; Splinter E; Ladetto M; Ferrero S
    Hematol Oncol; 2021 Aug; 39(3):293-303. PubMed ID: 33742718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma.
    Montoto S; López-Guillermo A; Colomer D; Esteve J; Bosch F; Ferrer A; Villamor N; Moreno C; Campo E; Montserrat E
    Leuk Lymphoma; 2003 Jan; 44(1):71-6. PubMed ID: 12691144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptic IGH/BCL2 rearrangements with variant FISH patterns in follicular lymphoma.
    Baró C; Espinet B; Salido M; García M; Sánchez B; Florensa L; Bellosillo B; Serrano S; Solé F
    Leuk Res; 2011 Feb; 35(2):256-9. PubMed ID: 20952062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
    Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
    Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characteristics and prognostic significance of Bcl-2/IgH gene rearrangement in Serbian follicular lymphoma patients.
    Radojkovic M; Ristic S; Colovic M; Cemerikic-Martinovic V; Radojkovic D; Krtolica K
    Neoplasma; 2008; 55(5):421-7. PubMed ID: 18665753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients.
    Macintyre EA; Belanger C; Debert C; Canioni D; Turhan AG; Azagury M; Hermine O; Varet B; Flandrin G; Schmitt C
    Blood; 1995 Dec; 86(12):4691-8. PubMed ID: 8541563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligonucleotide clonospecific probes directed against the junctional sequence of t(14;18): a new tool for the assessment of minimal residual disease in follicular lymphomas.
    Galoin S; al Saati T; Schlaifer D; Huynh A; Attal M; Delsol G
    Br J Haematol; 1996 Sep; 94(4):676-84. PubMed ID: 8826892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
    van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
    Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens.
    Spence JM; Rothberg PG; Wang N; Burack WR
    J Mol Diagn; 2011 May; 13(3):252-62. PubMed ID: 21497287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
    Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rearrangement of the 5' cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases.
    Yabumoto K; Akasaka T; Muramatsu M; Kadowaki N; Hayashi T; Ohno H; Fukuhara S; Okuma M
    Leukemia; 1996 Jun; 10(6):970-7. PubMed ID: 8667654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of rearrangements of the BCL2 major breakpoint region in follicular lymphomas. Correlation of polymerase chain reaction results with Southern blot analysis.
    Ladanyi M; Wang S
    Diagn Mol Pathol; 1992 Mar; 1(1):31-5. PubMed ID: 1342952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
    Della Starza I; De Novi LA; Cavalli M; Novelli N; Soscia R; Genuardi E; Mantoan B; Drandi D; Ferrante M; Monitillo L; Barbero D; Ciabatti E; Grassi S; Bomben R; Degan M; Gattei V; Galimberti S; Di Rocco A; Martelli M; Cortelazzo S; Guarini A; Foà R; Ladetto M; Ferrero S; Del Giudice I;
    Hematol Oncol; 2020 Dec; 38(5):698-704. PubMed ID: 32816326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
    Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M
    Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PCR analysis of IgH and BCL2 gene rearrangement in the diagnosis of follicular lymphoma in lymph node fine-needle aspiration. A critical appraisal.
    Aiello A; Delia D; Giardini R; Alasio L; Bartoli C; Pierotti MA; Pilotti S
    Diagn Mol Pathol; 1997 Jun; 6(3):154-60. PubMed ID: 9276187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the molecular staging and response in the management of follicular lymphoma patients.
    Arcaini L; Colombo N; Bernasconi P; Calatroni S; Passamonti F; Orlandi E; Bonfichi M; Burcheri S; Porta MD; Rumi E; Montanari F; Algarotti A; Pascutto C; Lazzarino M
    Leuk Lymphoma; 2006 Jun; 47(6):1018-22. PubMed ID: 16840191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.
    Gimenez E; Chauvet M; Rabin L; Puteaud I; Duley S; Hamaidia S; Bruder J; Rolland-Neyret V; Le Gouill S; Tournilhac O; Voog E; Maisonneuve H; Jacob MC; Leroux D; Béné MC; Formisano-Tréziny C; Gabert J; Gressin R; Callanan MB
    Br J Haematol; 2012 Jul; 158(2):186-197. PubMed ID: 22626453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
    Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
    Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia.
    Della Starza I; Nunes V; Cavalli M; De Novi LA; Ilari C; Apicella V; Vitale A; Testi AM; Del Giudice I; Chiaretti S; Foà R; Guarini A
    Br J Haematol; 2016 Aug; 174(4):541-9. PubMed ID: 27172403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.